Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Reza J. Mehran(The University of Texas MD Anderson Cancer Center), Lei Feng(The University of Texas MD Anderson Cancer Center), Vivek Verma(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(The University of Texas MD Anderson Cancer Center), James W. Welsh(The University of Texas MD Anderson Cancer Center), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Michael S. O’Reilly(The University of Texas MD Anderson Cancer Center), Melenda Jeter(The University of Texas MD Anderson Cancer Center), Peter Balter(The University of Texas MD Anderson Cancer Center), Stephen E. McRae(The University of Texas MD Anderson Cancer Center), Donald A. Berry(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Jack A. Roth(The University of Texas MD Anderson Cancer Center), Mara B. Antonoff, Wayne Hofstetter, Ravi Rajaram, David C. Rice, Boris Sepesi, Stephen G. Swisher(The University of Texas MD Anderson Cancer Center), Ara A. Vaporciyan, Garrett L. Walsh, Craig DeGraaf, Arlene M. Correa, Aileen B. Chen, Saumil Gandhi, Ritsuko Komaki, Percy Lee, Quynh‐Nhu Nguyen, Matthew S. Ning, Song Gao, Julianne Pollard‐Larkin, P Nitsch, R Sadagopan, Xiaochun Wang
The Lancet Oncology
September 13, 2021
Cited by 311Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis